412
C.A. Gray et al. / Phytochemistry 63 (2003) 409–413
H3-19) ppm; 13C NMR (CDCl3, 100 MHz) ꢀ 201.7 (s, C-
7), 168.9 (s, C-9), 143.1 (d, C-15), 138.7 (d, C-16), 127.4
(s, C-8), 124.3 (s, C-13), 110.5 (d, C-14), 73.3 (d, C-6),
56.7 (d, C-5), 42.8 (t, C-3), 42.5 (s, C-10), 36.7 (t, C-1),
35.8 (q, C-18), 34.0 (s, C-4), 30.6 (t, C-11), 24.0 (t, C-12),
22.0 (q, C-19), 19.4 (q, C-20), 18.6 (t, C-2), 11.6 (q, C-17)
ppm; EIMS m/z (rel. int.) 316 [M+] (5), 301 (100), 283
(45), 255 (16), 229 (11), 192 (10), 175 (12), 161 (29), 135
(12), 91 (17); HRFABMS m/z 317.2117 (calc. for
C20H29O3 [(M+H)+], 317.2117).
(1H, d, J=13.4 Hz, H-6), 2.55 (2H, m, H2-12), 2.49 (1H,
m, H-11a), 2.44 (1H, m, H-11b), 2.19 (3H, s, 6-OAc),
2.04 (1H, d, J=13.2 Hz, H-5), 1.99 (1H, br d, J=11.6
Hz, H-1a), 1.76 (3H, s, H3-17), 1.68 (1H, tt, J=13.6, 3.2
Hz, H-2a), 1.60 (1H, m, H-2b), 1.45 (1H, br d, J=13.3
Hz, H-3a), 1.42 (1H, td, J=12.9, 3.7 Hz, H-1b), 1.29
(1H, td, J=13.6, 4.1 Hz, H-3b), 1.28 (3H, s, H3-20), 1.05
(3H, s, H3-18), 1.01 (3H, s, H3-19) ppm; 13C NMR
(CDCl3, 100 MHz) ꢀ 194.6 (s, C-7), 170.4 (s, 6-OAc),
166.9 (s, C-9), 143.1 (d, C-15), 138.7 (d, C-16), 128.9 (s,
C-8), 124.2 (s, C-13), 110.5 (d, C-14), 74.7 (d, C-6), 53.8
(d, C-5), 42.7 (t, C-3), 42.6 (s, C-10), 36.5 (t, C-1), 35.6
(q, C-18), 33.5 (s, C-4), 30.4 (t, C-11), 24.1 (t, C-12), 21.9
(q, C-19), 21.3 (q, 6-OAc), 19.9 (q, C-20), 18.5 (t, C-2),
11.6 (q, C-17) ppm; EIMS m/z (rel. int.) 358 [M+] (4),
343 (25), 298 (62), 283 (84), 265 (45), 255 (100), 203 (57),
189 (78), 175 (41), 161 (91); HRFABMS m/z 359.2222
(calc. for C22H31O4 [(M+H)+], 359.2222).
3.3.3. 6ꢃ-Hydroxy-15,16-epoxylabda-8,13(16),14-trien-
7-one (3)
26
ꢁ
White crystalline solid; mp 99–100 C; [a]D +17ꢁ (c
1.01, CHCl3), lit. ꢀ34ꢁ (Rustaiyan et al., 1995); IR ꢁmax
3402 (br), 2930, 2856, 1651, 1604, 1470, 1385, 1026, 874,
782 cmꢀ1; 1H and 13C NMR see Table 2; EIMS m/z (rel.
int.) 316 [M+] (10), 314 (15), 301 (63), 283 (46), 255
(29), 203 (68), 192 (100), 175 (47), 161 (94), 151 (53);
HRFABMS m/z 317.2117 (calc. for C20 H29O3
[(M+H)+], 317.2117).
3.4.2. 6ꢃ-Acetoxy-14,15-epoxylabda-8,13(16),14-trien-
7-one (4)
Colourless oil; [a]2D6 ꢀ61ꢁ (c 1.04, CHCl3); IR ꢁmax
2932, 2863, 1747, 1668, 1606, 1471, 1370, 1230, 1027,
874, 600 cmꢀ1; 1H NMR (CDCl3, 400 MHz) ꢀ 7.37 (1H,
t, J=1.6 Hz, H-15), 7.27 (1H, br s, H-16), 6.31 (1H, d,
J=0.8 Hz, H-14), 5.79 (1H, d, J=3.3 Hz, H-6), 2.58
(2H, m, H2-12), 2.53 (1H, m, H-11a), 2.50 (1H, m,
H-11b), 2.06 (3H, s, 6-OAc), 1.96 (1H, br d, J=12.5 Hz,
H-1a), 1.85 (3H, s, H3-17), 1.77 (1H, tt, J=13.8, 3.3 Hz,
H-2a), 1.76 (1H, d, J=3.3 Hz, H-5), 1.62 (1H, dt,
J=14.1, 3.5 Hz, H-2b), 1.46 (1H, dd, J=13.2, 1.2 Hz,
H-3a), 1.42 (3H, s, H3-20), 1.37 (1H, td, J=13.1, 3.8 Hz,
H-1b), 1.24 (1H, td, J=13.4, 3.8 Hz, H-3b), 1.05 (3H, s,
H3-18), 1.04 (3H, s, H3-19) ppm; 13C NMR (CDCl3, 100
MHz) ꢀ 193.5 (s, C-7), 169.6 (s, 6-OAc), 168.5 (s, C-9),
143.1 (d, C-15), 138.7 (d, C-16), 129.3 (s, C-8), 124.4 (s,
C-13), 110.5 (d, C-14), 70.2 (d, C-6), 53.0 (d, C-5), 43.6
(t, C-3), 41.1 (s, C-10), 37.6 (t, C-1), 33.8 (s, C-4), 32.5
(q, C-18), 30.7 (t, C-11), 24.3 (t, C-12), 23.0 (q, C-19),
21.8 (q, C-20), 21.4 (q, 6-OAc), 18.6 (t, C-2), 11.7 (q, C-
17) ppm; EIMS m/z (rel. int.) 358 [M+] (2), 298 (58),
283 (63), 265 (36), 255 (100), 234 (46), 203 (68), 192 (88),
161 (95), 81(21); HRFABMS m/z 359.2222 (calcd for
C22H31O4 [(M+H)+], 359.2222).
3.4. ꢂ0-Acetoxylation of hispanone (2)
Hispanone (2, 499 mg, 1.66 mmol) was dissolved in
dry C6H6 (50 ml), dry Mn(OAc)3 (2.50 g; dried over
ꢁ
P2O5 at 70 C and 0.5 mmHg for 6 h immediately prior
to use) added and the resulting brown suspension
heated under reflux with exclusion of moisture for 72 h.
The heterogeneous reaction mixture was then cooled
and the fine brown precipitate dissolved by vigorous
stirring with 10% aqueous Na2S2O5 (30 ml) for 30 min.
Conc. HCl (3.0 ml) was added (to give a 0.9 M HCl soln
in the aqueous phase) and the mixture stirred for a fur-
ther 10 min. The organic and aqueous phases were then
separated, the aqueous phase thoroughly washed with
EtOAc (4ꢂ25 ml) and the combined organic phases
washed with 5% NaHCO3 (10 ml) and H2O (10 ml).
Drying with MgSO4 and evaporation of the solvent
gave a yellow oil (636 mg) that was purified by silica gel
column chromatography (7:3 hexane/EtOAc) to yield a
1
2:1 mixture (by H NMR spectroscopy) of 6a- and 6b-
acetoxy-14,15-epoxylabda-8,13(16),14-trien-7-one
(6
and 4) as a pale yellow oil (529 mg, 1.48 mmol, 89%).
Normal phase semi-preparative HPLC of a portion (501
mg) of the diastereomeric mixture in hexane-EtOAc
(9:1) afforded the pure acetoxy enones 6 (323 mg) and 4
(169 mg) as colourless oils.
3.5. Acetylation of 6ꢃ-hydroxy-14,15-epoxylabda-
8,13(16),14-trien-7-one (3)
Compound 3 (15 mg) was dissolved in pyridine (0.5
ml) and Ac2O (0.5 ml) and stirred at room temperature
over-night before MeOH (1 ml) was added and the
resulting soln. concentrated in vacuo to give a yellow oil
(22 mg). The reaction product was passed through a
small column of silica gel in hexane–EtOAc (7:3) to
yield a colourless oil (16 mg, [a]2D7 ꢀ53ꢁ) that was iden-
tical to keto-ester 4 in all respects.
3.4.1. 6ꢂ-Acetoxy-14,15-epoxylabda-8,13(16),14-trien-
7-one (6)
Colourless oil; [a]2D5 +50ꢁ (c 1.00, CHCl3), lit. +38ꢁ
(Garcia-Alvarez et al., 1981); IR ꢁmax 2932, 2872, 1747,
1674, 1614, 1470, 1373, 1235, 1025, 874 cmꢀ1; 1H NMR
(CDCl3, 400 MHz) ꢀ 7.36 (1H, t, J=1.6 Hz, H-15), 7.26
(1H, br s, H-16), 6.29 (1H, d, J=0.8 Hz, H-14), 5.64